User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test

The urgent need to scale up testing capacity during the COVID-19 pandemic has prompted the rapid development of point-of-care diagnostic tools such as lateral flow immunoassays (LFIA) for large-scale community-based rapid testing. However, studies of how the general public perform when using LFIA te...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Min, Bond, Raymond, Robertson, Louise J., Moore, Julie, Kowalczyk, Amanda, Price, Ruth, Burns, William, Nesbit, M. Andrew, McLaughlin, James, Moore, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782985/
https://www.ncbi.nlm.nih.gov/pubmed/35064150
http://dx.doi.org/10.1038/s41598-022-05097-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782985/
https://www.ncbi.nlm.nih.gov/pubmed/35064150
http://dx.doi.org/10.1038/s41598-022-05097-y

Ejemplares similares